Keyphrases
Cystic Fibrosis
100%
Changing Epidemiology
100%
Bacteriology
100%
Patient Registry
100%
Pseudomonas Aeruginosa (P. aeruginosa)
66%
Staphylococcus Aureus
50%
Complex Species
50%
Mycobacterium Tuberculosis (M. tb)
50%
Stenotrophomonas Maltophilia
50%
Burkholderia Cepacia Complex
50%
Epidemiology
33%
Country Groups
33%
Gross National Income
33%
Clinical Research
16%
Europe
16%
Age-specific
16%
All Ages
16%
High Prevalence
16%
Socioeconomic Status
16%
Low Prevalence
16%
Clinical Care
16%
Epidemiological Data
16%
Clinical Management
16%
Annual Incidence
16%
Chronic Infection
16%
Infection Control
16%
Monitoring Change
16%
Clinical Infections
16%
Cumulative Prevalence
16%
Background Monitoring
16%
Country Income Level
16%
Research Quality
16%
Medicine and Dentistry
Prevalence
100%
Cohort Effect
100%
Patient Registry
100%
Cystic Fibrosis
100%
Pathogen
75%
Pseudomonas aeruginosa
50%
Staphylococcus Aureus
37%
Atypical Mycobacterium
37%
Stenotrophomonas maltophilia
37%
Burkholderia Cepacia Complex
37%
Clinical Research
12%
Infection
12%
Socioeconomic Status
12%
Clinical Management
12%
Quality Improvement
12%
Infection Control
12%
Immunology and Microbiology
Prevalence
100%
Bacteriology
100%
Infectious Agent
75%
Pseudomonas aeruginosa
50%
Staphylococcus Aureus
37%
Nontuberculous mycobacteria
37%
Stenotrophomonas maltophilia
37%
Burkholderia Cepacia Complex
37%